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SignallingThe four secreted R-spondin (Rspo1-4) proteins of vertebrates function as stem cell growth factors and
potentiate canonical Wnt signalling. Rspo proteins act by cross-linking members of two cell surface
receptor families, complexing the stem cell markers LGR4-6 with the Frizzled-speciﬁc E3 ubiquitin
ligases ZNRF3/RNF43. The consequent internalisation of the ternary LGR–Rspo–E3 complex removes
the E3 ligase activity, which otherwise targets the Wnt receptor Frizzled for degradation, and thus
enhances Wnt signalling. Multiple combinations of LGR4-6, Rspo1-4 and ZNRF3/RNF43 are possible,
implying the existence of generic interaction determinants, but also of speciﬁc differences in complex
architecture and activity. We present here a high resolution crystal structure of an ectodomain variant
of human LGR5 (hLGR5ecto) complexed with a signalling competent fragment of mouse Rspo2
(mRspo2Fu1-Fu2). The structure shows that the particularly potent Rspo2 ligand engages LGR5 in a fashion
almost identical to that reported for hRSPO1. Comparison of our hLGR5ecto structure with previously
published structures highlights a surprising plasticity of the LGR ectodomains, characterised by a nearly
9 or larger rotation of the N-terminal half of the horseshoe-like fold relative to the C-terminal half. We
also report a low resolution hLGR5–mRspo2Fu1-Fu2–mZNRF3ecto ternary complex structure. This crystal
structure conﬁrms our previously suggested hypothesis, showing that Rspo proteins cross-link LGRs
and ZNRF3 into a 2:2:2 complex, whereas a 1:1:1 complex is formed with RNF43.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Signalling by the Wnt family of secreted glycolipoproteins is
considered to be one of the most fundamental developmental sig-
nalling pathways and occurs in all animals that share a primary
body axis (Holstein, 2012). Due to its crucial roles in embryonic
development and tissue homeostasis it is subject to a
multi-layered system of regulation (Clevers and Nusse, 2012;
Niehrs, 2012; Malinauskas and Jones, 2014). A multitude of Wnt
antagonists are secreted which function by blocking receptor
access (Semenov et al., 2001; Mao et al., 2001; Semenov et al.,
2005), sequestering Wnt ligands (Wang et al., 1997; Leyns et
al., 1997; Malinauskas et al., 2011) or degrading Wnt (Zhang
et al., 2012; Kakugawa et al., 2015; Zhang et al., 2015). In contrast,R-spondins (Rspo1-4) are the sole secreted potentiators of Wnt
signalling (Kazanskaya et al., 2004) and have emerged as crucial
regulators of stem cell maintenance in vivo and in vitro (Sato
et al., 2009; de Lau et al., 2014). These stem cell growth factors
are found in regenerating tissue such as nail mesoderm (Blaydon
et al., 2006), hair follicle (Cadieu et al., 2009) and most prominently
in the intestinal epithelium (Kim et al., 2005). Structurally they
consist of two cysteine rich repeats (similar to those found in
Furin and henceforth referred to as Fu1 and Fu2, respectively),
which are necessary and sufﬁcient for Wnt activation, as well
as a C-terminal Thrombospondin-related domain (TSR) and a
positively charged, ﬂexible tail.
At the level of molecular mechanism Rspo proteins potentiate
Wnt signalling by alleviating the feedback inhibition effected by
the transmembrane E3 ligases ZNRF3 and RNF43 (de Lau et al.,
2014). These two homologs whose expression is up-regulated by
canonical Wnt signalling have been found to speciﬁcally target
the cell surface Wnt receptors of the GPCR-like Frizzled family
for degradation (Koo et al., 2012; Hao et al., 2012). Rspo1-4 bind
to the extracellular PA domain (from protease associated) of these
E3 ligases with different afﬁnities which are correlated to their
potency in cell-based assays (Kim et al., 2008; Zebisch et al.,
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is not sufﬁcient to stop ubiquitination of Frizzled and enhance Wnt
signalling. This further requires simultaneous binding of Rspo to
the large leucine-rich repeat (LRR) containing ectodomain of LGR
receptors 4, 5 or 6, which are well established GPCR-like regulators
of stem cell function (Carmon et al., 2011; de Lau et al., 2011;
Glinka et al., 2011; Ruffner et al., 2012; Xie et al., 2013). The
ternary complex between Rspo and its two receptors LGR4-6 and
ZNRF3/RNF43 is established via extracellular recognition and
triggers by an unknown mechanism its rapid internalisation. This
results in efﬁcient removal of the E3 ligases from the cell surface
and hence increases Wnt signalling through Frizzled.
A plethora of crystal structures of Rspo alone and in complex
with LGR4 or -5, ZNRF3 or RNF43 were published in 2013 (Wang
et al., 2013; Chen et al., 2013; Zebisch et al., 2013; Peng et al.,
2013a; Peng et al., 2013b), deﬁning key elements of the LGR–
Rspo–E3 complex only two years after the identiﬁcation of this
elaborate mechanism for potentiating Wnt signalling. All LGR com-
plex structures published to date (Xu et al., 2013; Wang et al.,
2013; Chen et al., 2013; Peng et al., 2013a) contain Rspo1 as bind-
ing partner rather than one of the more potent Rspo2 or -3 ligands
(Kim et al., 2008; Zebisch et al., 2013; Warner et al., 2015). One
paper described the crystal structure of a ternary LGR5–RSPO1–
RNF43 complex that displayed a clear 1:1:1 stoichiometry (Chen
et al., 2013). However, a dimeric arrangement of ZNRF3ecto was
found for multiple independent structure determinations of com-
plexes with hRSPO1 and Rspo2 as well as in most of the unliganded
crystal structures (Zebisch et al., 2013; Peng et al., 2013b). We
found that dimerisation was stabilized by Rspo ligand binding,
but also enhanced the ligand binding afﬁnities (Zebisch et al.,
2013). These observations prompted us to suggest that ternary
complexes involving ZNRF3 would have a 2:2:2 stoichiometry.
In order to further advance our understanding of the functional
properties of LGR–Rspo–E3 complexes we sought to detail the
interaction interface of the more potent Rspo2 ligand with
hLGR5ecto and to test our hypothesis concerning the stoichiometry
of the ternary complex. We describe here a high resolution struc-
ture of hLGR5ecto in complex with mRspo2Fu1-Fu2 and analyse the
ligand binding interface and receptor structural plasticity.
Furthermore we describe the structure of a ternary hLGR5–
mRspo2Fu1-Fu2–mZNRF3ecto complex solved at 5 Å resolution.2. Methods and materials
2.1. Large scale mammalian expression and protein puriﬁcation
Mouse Rspo2Fu1-Fu2 and ZNRF3ecto proteins were produced as
described (Zebisch et al., 2013). A cDNA clone for human LGR5
was obtained from the I.M.A.G.E. library. The ectodomain of
LGR4, -5, and -6 contains an unstructured loop just before the last
b strand of the horseshoe fold (in hLGR5 between C485 and V539).
This region forms in part a helical structure in the single PDB entry
4BSR. The relevance of this observation is however unclear due to
potentially stabilizing crystal packing interactions and the low
resolution of the structure. Before crystal structures of LGR
ectodomains were reported, we tested, but struggled to achieve
high level secretory expression for many LGR ectodomain
constructs. We only managed to obtain expression in experiments
with coexpression of a well expressing Rspo ligand. On inspection
of the ﬁrst crystal structures, we replaced the region A488-H537
(Chen et al., 2013; Peng et al., 2013a) by overlapping two step
PCR with a short NGNNGD linker and cloned the ectodomain
variant (R32-S543) into pHLsec H10 (Aricescu et al., 2006). The
mature hLGR5ecto protein after removal of the signal peptide
therefore had the sequence ETG-RGCPTH...FGVCEN-NGNNGD-SVQCSPS-GTHHHHHHHHHH (natural residues underscored).
Removal of the unstructured loop boosted the yield of expressed
protein by least ten fold compared to that obtained in earlier
trials. A complex of mRspo2Fu1-Fu2 (I39-G144, mature sequence
ETG-ICKGCL...MECVEG-THHHHHHHHHH) with hLGR5ecto was
obtained from cotransfection of HEK293T cells cultured in the
presence of 1 mg/l kifunensine (Cayman Chemicals).
Approximately 5 mg of complex could be obtained from 1 l of
mammalian cell culture. The dimeric protein complex was puriﬁed
as previously described for the mRspo2Fu1-Fu2–mZNRF3ecto
complex (Zebisch et al., 2013) but using 10 mM Tris/HCl pH 9.0,
250 mM NaCl as running buffer during gel ﬁltration.
2.2. Crystallisation and data collection
The hLGR5ecto–mRspo2Fu1-Fu2 complex was concentrated to
5.9 mg/ml and subjected to sitting drop vapour diffusion crystalli-
sation trials. A single crystal appeared after one month in 25%
(w/v) Polyethylene Glycol 3350, 200 mM Lithium Sulphate,
100 mM bis-Tris pH 5.5. For cryoprotection the crystal was trans-
ferred to reservoir solution to which 1/10 V PEG200 had been
added before dipping into liquid nitrogen.
To obtain the hLGR5ecto–mRspo2Fu1-Fu2–mZNRF3ecto complex
we mixed approximately stoichiometric amounts of the
hLGR5ecto–mRspo2Fu1-Fu2 complex and mZNRF3ecto in 10 mM
Tris/HCl pH 9.0, 1000 mM NaCl and adjusted the protein concen-
tration to 1.3 mg/ml. The presumed complex was subjected to sit-
ting drop vapour diffusion crystallisation trials mixing 300 nl of
protein with 100 nl reservoir. Crystals appeared after 10 days in
100 mM Ammonium Acetate, 600 mM NaCl, 50 mM MES pH 6.0,
5 mM MgSO4 and grew slowly over the course of three months.
For cryoprotection of these crystals the liquid around the crystals
in situwas exchanged six times to new liquid with linearly increas-
ing salt and glycerol content. The ﬁnal cryoprotection solution was
100 mM Ammonium Acetate, 3 M NaCl, 10% glycerol, 50 mM MES
pH 6.0, 5 mM MgSO4.
2.3. Structure determination
Diffraction data were collected at DIAMOND synchrotron light
source at the i04 beamline. The structure of the high resolution
hLGR5ecto–mRspo2Fu1-Fu2 complex was solved by Molecular
Replacement (MR) using the previously described hLGR5ecto–
hRSPO1Fu1-Fu2 complex as a starting model (Peng et al., 2013a).
For the ternary complex we obtained only a low resolution,
highly anisotropic dataset extending in the best direction to 4.8 Å
(I/rI = 2). The asymmetric unit contains a single hLGR5ecto–
mRspo2Fu1-Fu2–mZNRF3ecto complex. The 2:2:2 complex as
described in the Results section is generated by crystallographic
symmetry. To solve this structure we proceeded as follows.
Structure determination by MR was facilitated by anisotropic scal-
ing via the anisotropic diffraction server at the UCLA MBI (http://
services.mbi.ucla.edu/anisoscale/) which reported recommended
resolution limits along a⁄, b⁄ and c⁄ to be 5.7, 5.7, and 4.8 Å. We ﬁrst
tested all available LGR5ecto structures for the highest score in MR
using the PHASER program. The best model appeared to be chain A
of PDB entry 4BSU (Peng et al., 2013a) for which we obtained a sin-
gle solution with a Translation Function Z score (TFZ) of 12.6 and a
log likelihood gain (LLG) of 393 indicating a clear solution. With
hLGR5ecto in place we then compared MR scores for all available
mZNRF3ecto structures (Zebisch et al., 2013; Peng et al., 2013b)
and found chain C of PDB entry 4C99 (Zebisch et al., 2013) to give
the highest score (TFZ = 9.1, combined LLG = 573). After rigid body
reﬁnement in REFMAC strong density was apparent between the
concave side of hLGR5ecto and mZNRF3. mRspo2Fu1-Fu2 could not
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cysteine knot protein was not sampled by the available structures.
We hence placed Fu1 and Fu2 individually by superposing
Fu1-ZNRF3 and Fu2-LGR5 complexes onto the MR solutions. The
generated hLGR5ecto–mRspo2Fu1–mRspo2Fu2–mZNRF3ecto complex
was subjected to rigid body reﬁnement. As we observed a devia-
tion of the model from the electron density map between
b-hairpins 2 and 3 of Fu1, we deﬁned two rigid bodies for Rspo2:
I39-L75 and H76-C141. The geometry of L75-S77 was afterwards
idealised in COOT. We then performed restrained reﬁnement of
the coordinates against the original (uncorrected) diffraction data
using strong geometric restraints generated by PROSMART from
the available high resolution reference structures. The single
restrained reﬁnement step (20 cycles) was followed by 10 cycles
of structure idealisation. The ﬁnal model had an Rwork and Rfree of
27.0% and 31.3%, respectively.
2.4. Structural analysis
Superpositions of LGR ectodomains were performed with the
ALIGN program as implemented in PYMOL. Domain and hinge
identiﬁcation was performed using DYNDOM with standard set-
tings. Figures were produced in PYMOL and assembled in
PHOTOLINE32.
3. Results
3.1. The LGR5–Rspo2 binding interface
To provide insight into recognition of Rspo2 by LGR receptors
we crystallised a variant of the hLGR5 ectodomain (from which
an unstructured loop had been removed, see Methods) in complexTable 1
Data collection and reﬁnement statistics.
PDB code 4UFR
Complex hLGR5ecto–mRspo2Fu1-Fu
Stoichiometry 1:1
Data collection
X-ray source i04
Wavelength (Å) 1.0088
Space group C2
a, b, c (Å) 205.2, 59.8, 112.2
a, b, c () 90, 99.5, 90
Wilson B-factor (Å2) 37
Resolution range (Å) 69.19–2.20
(2.26–2.20)
Unique reﬂections 62167 (2968)
Average multiplicity 7.6 (2.6)
Completeness (%) 90.6 (59.6)
hI/rIi 10.8 (1.2)
Rmerge (all) (%) 12.5 (68.5)
Rpim (all) (%) 4.6 (45.0)
Reﬁnement
Rwork/Rfree (%) 20.9/26.2
No. of non H atoms
Protein 8756
Water 150
Ligands 6
Average B-factor (Å2)
Protein 62
Water 47
Ligands 63
r.m.s.d. from ideality
Bond lengths (Å) 0.0137
Bond angles () 1.7460
Ramachandran plot
Favoured (%) 90.7
Allowed (%) 99.9
Outliers (number) 1
Values in parentheses are for the highest-resolution shell.with the Furin tandem repeat of mRspo2 (Table 1, Fig. 1). The
crystal structure was solved at 2.2 Å and reﬁned to Rwork and Rfree
values of 20.9% and 26.0%. The asymmetric unit contains two
copies of the hLGR5ecto–mRspo2Fu1-Fu2 complex, which are essen-
tially identical (r.m.s.d. of 0.5 Å for 559 aligned Ca). A structural
superposition with the corresponding highest resolution complex
of hLGR5ecto–hRSPO1Fu1-Fu2 (PDB entry 4KNG (Chen et al., 2013))
reveals that almost identical residues are involved in the molecular
recognition. At the core of the interface is a hydrophobic interac-
tion site with the hallmark ‘phenylalanine clamp’ (Xu et al.,
2013; Wang et al., 2013; Chen et al., 2013; Peng et al., 2013a), in
this example F105 and F109 of Rspo2Fu2 pinching A190 of hLGR5.
These conserved hydrophobic core interactions are surrounded
by more polar interactions which differ in a subtle way from the
hLGR5–hRSPO1 interface (not all shown in ﬁgures): The side chain
of N123 is found to form a hydrogen bond with H76, an interaction
that was not previously seen. The salt bridge seen between R144 of
LGR5 and D85 of hRSPO1 is replaced with a water-mediated hydro-
gen bond to the backbone of C78 of mRspo2. In the hLGR5–hRSPO1
complex a further two hydrogen bonds are formed between Q189
and T238 to G123 and N109 respectively. These two hydrogen
bonds are not found in the complex described here. The overall
similarity in the complex structures is in agreement with the
promiscuity of Rspo–LGR binding and the observation that all
Rspo ligands bind LGR receptors with similar nanomolar afﬁnity
and potency being largely determined by interaction with the E3
ligases (Carmon et al., 2011; Zebisch et al., 2013).
3.2. A recurring LGR5 ectodomain dimer
For all four of their published crystal structures of hLGR5ecto–
hRSPO1Fu1-Fu2 complexes Peng et al. observed an identical packing4UFS
2 hLGR5ecto–mRspo2Fu1-Fu2–mZNRF3ecto
2:2:2 (1:1:1 per AU)
i04
0.9795
I422
188.6, 188.6, 165.3
90, 90, 90
212
39.47–4.80
(5.37–4.80)
7509 (2105)
5.9 (6.1)
99.4 (99.8)
8.5 (1.5)
16.1 (153.2)
7.1 (67.8)
27.0/31.3
5582
–
–
258
–
–
0.004
0.848
90.7
99.4
4
Fig. 2. A recurring dimeric arrangement of LGR receptor ectodomains. Superposition of hLGR5ecto–mRspo2Fu1-Fu2 (coloured) with the hLGR5ecto–hRSPO1Fu1-Fu2 complex (gray,
PDB entry 4BSR) in A and with the xLGR4ecto apo structure (gray, PDB entry 4LI1) in B.
Fig. 1. The hLGR5–mRspo2 binding interface in two views. (A) Overview of the binding interface. Only the N-terminal half of the LGR5 horseshoe fold is involved in ligand
binding. The relative orientation of hRSPO1 from PDB entry 4KNG was generated by superposing the N-terminal region of LGR5 (residues 96-308) and is displayed in gray.
(B) Close-up view on the binding site. Cysteine bridges are shown as yellow ball-and-sticks and dotted lines represent hydrogen bonds.
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wise different crystal lattices (Peng et al., 2013a). These observa-
tions initially prompted the suggestion that there may be a
recurring 2:2 stoichiometry for the LGR–Rspo interaction, how-
ever, subsequent structures have revealed a confusingly diverse
set of LGR–LGR packing interactions rather than one consistent
quaternary arrangement (de Lau et al., 2014). We observe the exact
same dimeric arrangement with a twofold rotational symmetry in
our structure as that seen by Peng et al. (Fig. 2A). The fact that allﬁve crystal structures are crystallographically unrelated and
resulted from diverse crystallisation conditions points to a high
propensity of the hLGR5 ectodomain to dimerize in this particular
fashion. This tendency to dimerize might even be higher in the
native membrane as the proteins would have fewer degrees of
motional freedom. The LGR5–LGR5 interface buries some 900 Å
of solvent accessible area. Residues involved in the dimer interface
include Y289, D290, Y361, H383, W407, H454 which interact in a
rather loose fashion, as judged from visual inspection of shape
M. Zebisch, E.Y. Jones / Journal of Structural Biology 191 (2015) 149–155 153complementarity (not shown), and are only partially conserved
across LGR4-6. Most notably however, we observe a very similar
dimer arrangement in the crystal structure of Xenopus (x)
LGR4ecto (Fig. 2B) pointing towards a conserved dimerisation mode.
The observed dimeric arrangement is compatible with simultane-
ous anchoring in cis to the same cell membrane (i.e. both
C-termini point in the same direction). However, as has been noted
earlier, this arrangement is not compatible with simultaneous
binding of RNF43 or ZNRF3 to Rspo (Zebisch et al., 2013; Peng
et al., 2013b). It remains to be established whether disruption of
ectodomain dimerisation may for the full integral membrane LGR
receptor be in some way involved in signal transmission by
R-spondins.
3.3. Structural plasticity of LGR ectodomains
During our structural comparisons of the herein described
hLGR5ecto–mRspo2Fu1-Fu2 complex with previously published
LGRecto structures we noticed surprisingly high r.m.s.d. values for
aligned Ca traces. As an example, superposition of the two LGR
chains of the complex described here to chain E of PDB entry
4BSU (hLGR5ecto–hRSPO1Fu1-Fu2 complex, that is 100% sequence
identity) resulted in an r.m.s.d. values of 1.8 and 1.9 Å, respectively.
The ectodomain structure of xLGR4 gave even higher r.m.s.d. val-
ues of up to 4.1 Å (56% sequence identity). Such high structural
deviations indicate structural rearrangements, i.e. domain move-
ments. We noticed that when the N-terminal or C-terminal regions
were superimposed separately the r.m.s.d. values achieved were
considerably lower (Fig. 3). For an accurate and quantitative anal-
ysis we employed the program DYNDOM as implemented in CCP4
(Hayward and Berendsen, 1998), which allows the identiﬁcation of
domain borders, hinge regions and associated domain rotation
axes based on comparison of different crystal structures.
In the case of LGR5 using the structure described here and chain
E of PDB entry 4BSU the program identiﬁed two domains (Fig. 3A).
Domain 1 (P35-F301) encompasses the ﬁrst 10 LRR and domain 2
(Q302-C541) consists of LRR 11-17. Residues I293, Q294, F295,
F301 and Q302 function as hinge regions mediating a domain rota-
tion of 9.6 around an axis approximately perpendicular to the
horseshoe fold. It is noticeable that the rotation axis and hinge
region is very close to residues F264 and F288 which have been
noticed earlier to disrupt the LRR fold (Peng et al., 2013a). Hence
the presence of these residues, at what are canonical leucine posi-
tions in the LRR sequence motif, likely contributes to the observed
dynamic properties. The structure described here represents theFig. 3. A hinge motion in LGR5 receptor ectodomains. (A) Superposition of the hLGR5ect
4BSU, gray, hRSPO1 not shown) based on the 10 N-terminal LRR. The C- and N-terminal re
rod. Calculated hinge residues are shown in green. Two phenylalanine side chains occup
hLGR5ecto–hRSPO1Fu1-Fu2 (pdb 4BSU, gray) to the apo form of xLGR4ecto (pdb: 4LI1) indica
up to 24.most tightly curved or concave conformation observed to date
for the LGR5 ectodomain. However, the ectodomain of LGR4 (Xu
et al., 2013) corresponds to an even more closed horseshoe. A com-
parison of LGR5 and LGR4 ectodomains suggests that a LGR recep-
tor may be capable of rotational ﬂexion of up to 24 within its
extracellular region (Fig. 3B). This ﬂexion does not appear to pro-
vide an induced ﬁt-type mechanism for binding to Rspo ligands.
However, it may contribute an element of adaptability needed
for the formation multi-subunit complexes with the various
combinations of Rspo ligands and ZNRF3/RNF43 ligases or other
as yet uncharacterised binding partners.
3.4. Architecture of the LGR5–Rspo–ZNRF3 complex
A multitude of crystal structures of Rspos with either LGR or
ZNRF3/RNF43 ectodomains have been published (Xu et al.,
2013; Wang et al., 2013; Chen et al., 2013; Zebisch et al., 2013;
Peng et al., 2013a; Peng et al., 2013b). Only a single structure
describes the architecture of Rspo in a ternary complex with ecto-
domains of both types of receptors, that is the hLGR5ecto–
hRSPO1Fu1-Fu2–hRNF43ecto complex (Chen et al., 2013). To obtain
insight into ternary complex formation with ZNRF3 we solved a
low resolution hLGR5ecto–mRspo2Fu1-Fu2–mZNRF3ecto complex
(see methods, Table 1 and Fig. 4). This complex is very similar to
the equivalent RNF43-containing complex in the overall position-
ing of the three different types of subunits. The RspoFu1-Fu2 frag-
ment is sandwiched between the two receptor ectodomains
which do not contact each other (Fig. 4A). Thus, a Rspo ligand
serves to heterodimerize an LGR receptor with an E3 receptor in
both ﬂavours of ternary complex. However, as previously proposed
by us (Zebisch et al., 2013) the ternary complex involving ZNRF3
adopts a clear 2:2:2 stoichiometry in the crystal lattice due to
dimerisation of the ZNRF3 ectodomain. Compared to the relative
position of RNF43 in the ternary complex, each ZNRF3 subunit is
rotated 30 away from its partner LGR5 (Fig. 4B). We note that
dimerisation of ZNRF3ecto and consequent 2:2:2 stoichiometry of
the ternary complex would not be compatible with the exact
arrangement of ligand and receptors as seen in the RNF43 ternary
complex due to clashes of the membrane-proximal regions of the
two LGR receptors (not shown). This rigid body shift in the position
of the ZNRF3/RNF43 relative to LGR also requires a re-orientation
of the Rspo2Fu1 domain to maintain the b-hairpin 1 and 2 mediated
interface with the E3 (Chen et al., 2013; Zebisch et al., 2013; Peng
et al., 2013b). The ﬂexibility of the Rspo Fu1-Fu2 linker has been
previously noted (Zebisch et al., 2013; Peng et al., 2013a). Hereo–mRspo2Fu1-Fu2 complex (this work, coloured) with hLGR5ecto–hRSPO1Fu1-Fu2 (pdb
gions can rotate as separate rigid bodies almost 10 around the axis shown as green
ying canonical leucine positions are shown in orange. (B) A similar comparison of
tes that the two segments of LGR ectodomains could undergo domain movements of
Fig. 4. Architecture of the ternary LGR–Rspo–ZNRF3 signalling complex. (A) The
ternary hLGR5ecto–mRspo2Fu1-Fu2–mZNRF3ecto complex adopts a 2:2:2 stoichiome-
try in the crystal lattice. LGR5 and ZNRF3 do not contact each other directly. The
2Fo–Fc density, depicted as chicken wire, is contoured at the 1r level (mRspo2Fu1-Fu2
blue-pink; hLGR5ecto magenta; mZNRF3ecto orange/yellow). (B) Comparison of the
two ternary LGR–Rspo–E3 complexes (1:1:1 complex for each) superimposed based
on hLGR5. Compared to the RNF43 complex (in gray) ZNRF3 (orange) together with
the Fu1 unit of Rspo2 rotates almost 30 around the axis shown in green. This is
required to avoid steric clashes in the membrane-proximal part of the two
receptors that would result from 2:2:2 complex formation (not shown).
154 M. Zebisch, E.Y. Jones / Journal of Structural Biology 191 (2015) 149–155we observe a slight twist before the third b-hairpins of Fu1 consis-
tent with it forming part of the mostly involved in LGR binding
(Cheng et al., 2011; Xu et al., 2013; Wang et al., 2013; Peng
et al., 2013a). It appears that the difference in relative orientation
of the LGR and E3 receptors for the RNF3 versus ZNRF43 ternary
complex renders this ﬂexibility a necessity for Rspo to function
as a cross-linker in both contexts.
4. Discussion and conclusions
R-spondins are important stem cell growth factors with
reported roles in tissue regeneration, but also cancer progression
(Kim et al., 2005; Zhao et al., 2009; Seshagiri et al., 2012;
Papapietro et al., 2013). An understanding of the basic principles
behind R-spondin signalling is fundamental to the design of noveltherapeutic interventions for cases where the Wnt pathway is
deregulated. We provide here detailed insights into the recognition
of Rspo2 by LGR5. These insights can inform the development of
potency-enhanced artiﬁcial Rspo molecules (Moad and Pioszak,
2013; Warner et al., 2015) for example, to enhance tissue regener-
ation. Conversely, our mapping of the interaction determinants can
also facilitate the design of Rspo antagonistic binding molecules,
with potential applications in ﬁghting Wnt driven cancers.
Our crystallographic analysis has added to the previously
reported observations that LGR receptor ectodomains have a
propensity to dimerize in a speciﬁc symmetrical fashion (Peng
et al., 2013a; de Lau et al., 2014). Despite the multiple examples
of this behaviour occurring in otherwise unrelated crystal packing
arrangements, the functional relevance of LGR receptor
homo-dimerisation remains speculative for now. One possibility
is that disruption of the LGR dimer during formation of LGR–
Rspo–E3 complexes may be involved in R-spondin signal
transmission.
It has previously been noted that the horseshoe fold of LGR
ectodomains is partially split into two segments (Wang et al.,
2013; Peng et al., 2013a). We have shown here for the ﬁrst time
that the N-terminal and C-terminal regions behave as separate
rigid bodies, i.e. domains that can undergo relative domain
motions of up to 10, and possibly as much as 24. Only the
N-terminal 10 LRRs are involved in ligand binding. What is the
function of the C-terminal region of the horseshoe fold? This region
has a slightly lower sequence conservation across homologs as
compared to the ligand binding domain. It may well be that the
sole function of this region is to provide a sturdy linker between
the ligand binding region and the transmembrane domain so as
to place tight limits on the relative positions of the transmembrane
and cytosolic regions for R-spondin cross-bridged E3 ligases and
LGR receptors. An additional possibility is that this region harbours
determinants for association with the Wnt receptors Frizzled and
LRP5/6 (de Lau et al., 2011; Carmon et al., 2012).
Our crystallographic LGR5–Rspo–ZNRF3 complex, albeit at low
resolution, conﬁrms the 2:2:2 stoichiometry that we had hypothe-
sised would be favoured for ternary complexes involving ZNRF3
(Zebisch et al., 2013), as opposed to the 1:1:1 stoichiometry seen
for the corresponding RNF43 complex (Chen et al., 2013). This con-
trast in ternary complex composition was unsuspected given the
apparent similarity in sequence and function of ZNRF3 and
RNF43. However, the difference in dimerisation potential between
the two E3 ligase ectodomains is apparent on detailed structural
analysis. RNF43 lacks the structural determinants that favour
dimerisation in ZNRF3, and ZNRF3 dimerisation is strongly
enhanced by Rspo ligand binding (Zebisch et al., 2013). This clear
difference in the behaviour of two, modestly conserved, E3 ligases
calls for further studies to uncover functional differences and their
physiological implications.Conﬂict of interest
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